Cargando…
Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance
INTRODUCTION: Deep Ensemble for Recognition of Malignancy (DERM) is an artificial intelligence as a medical device (AIaMD) tool for skin lesion assessment. METHODS: We report prospective real-world performance from its deployment within skin cancer pathways at two National Health Service hospitals (...
Autores principales: | Thomas, Lucy, Hyde, Chris, Mullarkey, Dan, Greenhalgh, Jack, Kalsi, Dilraj, Ko, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645139/ https://www.ncbi.nlm.nih.gov/pubmed/38020164 http://dx.doi.org/10.3389/fmed.2023.1264846 |
Ejemplares similares
-
Effectiveness of an image analyzing AI-based Digital Health Technology to identify Non-Melanoma Skin Cancer and other skin lesions: results of the DERM-003 study
por: Marsden, Helen, et al.
Publicado: (2023) -
Japanese Physicians’ Views on Drug Post-Marketing Surveillance
por: Maeda, Kazuki, et al.
Publicado: (2015) -
Post-marketing safety surveillance of the rotavirus vaccine in India
por: Kang, Gagandeep, et al.
Publicado: (2023) -
Analysis of Post-Deployment Cognitive Performance and Symptom Recovery in U.S. Marines
por: Haran, F. J., et al.
Publicado: (2013) -
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
por: Kim, Hyeongyeong, et al.
Publicado: (2021)